On Demand Webinar High Throughput Biomarker Discovery For Clinical Trial Optimization

Summary

Advances in mass spectrometry resolution and sensitivity have enabled increasingly comprehensive views into the multitude of ... P.A.C.E Credits Description: ( labroots.com/credit/pace-credits/9474/cert) Presented By: Dawn Waterworth Executive ... We're excited to continue our 2026 PEAKS® Sergio Mosquim Junior presents the development of an HT Disease heterogeneity creates heterogeneity in patients' treatment responsiveness, which in turn drives up Parker Ruth from Stanford University shares the latest findings from a Dr. Bernie Zeiher, President, Development at Astellas, explains how Presenters and Panelists: Jiri Aubrecht, Pharm D, PhD; Tanja Zabka, DVM, DACVP, DSP; Warren Glaab, PhD; Gary Friedman, ... Learn more at invitrogen.com/protoarray This video describes how customers can identify and then validate markers. Presented By: Jenny Koenitzer, PhD Speaker Biography: Dr. Koenitzer is an immunobiologist in R&D at Bristol Myers Squibb in ... Join us for an insightful FDA Grand Rounds presentation featuring Dr. Richard Beger, Branch Chief of the Omics Modeling, ...